Los Angeles — Los Angeles, California

Los Angeles is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Los Angeles has participated in 11 clinical trials with 1 currently active.

Therapeutic areas: Clostridium Difficile Infection Recurrence, Non-infectious Anterior Uveitis, Uveitic Glaucoma.

Sponsors: Finch Research and Development LLC., Tarsier Pharma, Rebiotix Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Los Angeles?

Los Angeles has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Los Angeles conducted?

Los Angeles has 11 clinical trials on record, with 1 currently active. Their work covers Clostridium Difficile Infection Recurrence, Non-infectious Anterior Uveitis, Uveitic Glaucoma.

Is Los Angeles accredited by Crixeo Health?

Yes — Los Angeles holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Los Angeles?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.